Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
J Mol Diagn. 2021 Dec;23(12):1732-1740. doi: 10.1016/j.jmoldx.2021.08.013.
Complex insertion-deletion (indel) events in the globin genes manifest in widely variable clinical phenotypes. Many are incompletely characterized because of a historic lack of efficient methods. A more complete assessment enables improved prediction of clinical impact, which guides emerging therapeutic choices. Current methods have limited capacity for breakpoint assignment and accurate assessment of mutation extent, especially in cases containing duplications or multiple deletions and insertions. Technology, such as long-read sequencing, holds promise for significant impact in the characterization of indel events because of read lengths that span large regions, resulting in improved resolution. Four known complex β-globin gene cluster indel types were assessed using single-molecule, real-time sequencing technology and showed high correlation with previous reports, including the Caribbean locus control deletion (g.5,305,478_5,310,336del), a large β-gene duplication containing the Hb S mutation (g.4,640,335_5,290,171dup with g.5,248,232T>A, c.20A>T; variant allele fraction, 64%), and two nested variants (double deletions with intervening inversion): the Indian γ(γδβ)-thalassemia (g.5,246,804-5,254,275del, g.5,254,276_5,269,600inv, and g.5,269,601_5,270,442del) and the Turkish/Macedonian (δβ) thalassemia (g.5,235,064_5,236,652del, g.5,236,653_5,244,280inv, and g.5,244,281_5,255,766del). Our data confirm long-read sequencing as an efficient and accurate method to identify these clinically significant complex events. Limitations include high-complexity sample preparation requirements, which hinder routine use in clinical laboratories. Continued improvements in sample and data workflow processes are needed to accommodate volumes in a tertiary clinical laboratory.
珠蛋白基因中的复杂插入-缺失(indel)事件表现出广泛的临床表型差异。由于历史上缺乏有效的方法,许多 indel 事件都没有得到完全描述。更全面的评估可以提高对临床影响的预测能力,从而指导新兴的治疗选择。目前的方法在断点分配和准确评估突变程度方面的能力有限,尤其是在包含重复或多个缺失和插入的情况下。长读测序等技术有望在 indel 事件的特征描述中产生重大影响,因为其读长可以跨越大片区域,从而提高分辨率。使用单分子实时测序技术对四种已知的复杂β-珠蛋白基因簇 indel 类型进行了评估,结果与之前的报道高度相关,包括加勒比地区控制缺失(g.5,305,478_5,310,336del)、包含 Hb S 突变的大型β-基因重复(g.4,640,335_5,290,171dup 伴有 g.5,248,232T>A, c.20A>T;变异等位基因分数,64%)和两个嵌套变体(带有中间反转的双缺失):印度γ(γδβ)-地中海贫血(g.5,246,804-5,254,275del、g.5,254,276_5,269,600inv 和 g.5,269,601_5,270,442del)和土耳其/马其顿(δβ)地中海贫血(g.5,235,064_5,236,652del、g.5,236,653_5,244,280inv 和 g.5,244,281_5,255,766del)。我们的数据证实,长读测序是一种高效、准确的方法,可以识别这些具有临床意义的复杂事件。该方法的局限性包括对高复杂度样本制备的要求,这阻碍了其在临床实验室中的常规使用。需要继续改进样本和数据工作流程,以适应三级临床实验室的工作量。